Sagawa, T., Sato, Y., Hirakawa, M., Hamaguchi, K., Fukuya, A., Okamoto, K., . . . Takayama, T. (2020). Clinical impact of primary tumour location, early tumour shrinkage, and depth of response in the treatment of metastatic colorectal cancer with first-line chemotherapy plus cetuximab or bevacizumab. Sci Rep.
Citação norma ChicagoSagawa, Tamotsu, et al. "Clinical Impact of Primary Tumour Location, Early Tumour Shrinkage, and Depth of Response in the Treatment of Metastatic Colorectal Cancer With First-line Chemotherapy Plus Cetuximab or Bevacizumab." Sci Rep 2020.
MLA引文Sagawa, Tamotsu, et al. "Clinical Impact of Primary Tumour Location, Early Tumour Shrinkage, and Depth of Response in the Treatment of Metastatic Colorectal Cancer With First-line Chemotherapy Plus Cetuximab or Bevacizumab." Sci Rep 2020.